Protective effect of policosanol on atherosclerotic lesions in rabbits with exogenous hypercholesterolemia

被引:32
作者
Arruzazabala, ML [1 ]
Noa, M [1 ]
Menéndez, R [1 ]
Más, R [1 ]
Carbajal, D [1 ]
Valdés, S [1 ]
Molina, V [1 ]
机构
[1] Natl Ctr Sci Res, Ctr Natl Prod, Dept Pharmacol, Histol Lab, Havana, Cuba
关键词
policosanol; atherosclerotic lesions; exogenous hypercholesterolemia; rabbits;
D O I
10.1590/S0100-879X2000000700015
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Policosanol is a mixture of higher aliphatic alcohols purified from sugar cane wax, with cholesterol-lowering effects demonstrable in experimental models and in patients with type LI hypercholesterolemia. The protective effects of policosanol on atherosclerotic lesions experimentally induced by lipofundin in rabbits and rats and spontaneously developed in stumptail monkeys have been described. The present study was conducted to determine whether policosanol administered orally to rabbits with exogenous hypercholesterolemia also protects against the development of atherosclerotic lesions. Male New Zealand rabbits weighing 1.5 to 2 kg were randomly divided into three experimental groups which received 25 or 200 mg/kg policosanol (N = 7) orally for 60 days with acacia gum as vehicle or acacia gum alone (control group, N = 9). All animals received a cholesterol-rich diet (0.5%) during the entire period. Control animals developed marked hypercholesterolemia, macroscopic lesions and arterial intimal thickening. Intima thickness was significantly less (32.5 +/- 7 and 25.4 +/- 4 mu m) in hypercholesterolemic rabbits treated with policosanol than in controls (57.6 +/- 9 mu m). In most policosanol-treated animals, atherosclerotic lesions were not present, and in others, thickness of fatty streaks had less foam cell layers than in controls. We conclude that policosanol has a protective effect on the atherosclerotic lesions occurring in this experimental model.
引用
收藏
页码:835 / 840
页数:6
相关论文
共 40 条
[1]   A 12-MONTH STUDY OF POLICOSANOL ORAL TOXICITY IN SPRAGUE-DAWLEY RATS [J].
ALEMAN, CL ;
MAS, R ;
HERNANDEZ, C ;
RODEIRO, I ;
CEREJIDO, E ;
NOA, M ;
CAPOTE, A ;
MENENDEZ, R ;
AMOR, A ;
FRAGA, V ;
SOTOLONGO, V ;
JIMENEZ, S .
TOXICOLOGY LETTERS, 1994, 70 (01) :77-87
[2]   CARCINOGENICITY OF POLICOSANOL IN SPRAGUE-DAWLEY RATS - A 24-MONTH STUDY [J].
ALEMAN, CL ;
FERREIRO, RM ;
PUIG, MN ;
GUERRA, IR ;
ORTEGA, CH ;
CAPOTE, A .
TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS, 1994, 14 (05) :239-249
[3]   RELATIVE RATES OF STEROL SYNTHESIS IN THE LIVER AND VARIOUS EXTRA-HEPATIC TISSUES OF NORMAL AND CHOLESTEROL-FED RABBITS - RELATIONSHIP TO PLASMA-LIPOPROTEIN AND TISSUE CHOLESTEROL LEVELS [J].
ANDERSEN, JM ;
TURLEY, SD ;
DIETSCHY, JM .
BIOCHIMICA ET BIOPHYSICA ACTA, 1982, 711 (03) :421-430
[4]   EFFECT OF POLICOSANOL IN LOWERING CHOLESTEROL LEVELS IN PATIENTS WITH TYPE-II HYPERCHOLESTEROLEMIA [J].
ANEIROS, E ;
MAS, R ;
CALDERON, B ;
ILLNAIT, J ;
FERNANDEZ, L ;
CASTANO, G ;
FERNANDEZ, JC .
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1995, 56 (02) :176-182
[5]   EFFECT OF SUCCESSIVE DOSE INCREASES OF POLICOSANOL ON THE LIPID PROFILE AND TOLERABILITY OF TREATMENT [J].
ANEIROS, E ;
CALDERON, B ;
MAS, R ;
ILLNAIT, J ;
CASTANO, G ;
FERNANDEZ, L ;
FERNANDEZ, JC .
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1993, 54 (03) :304-312
[6]  
Arruzazabala M L, 1994, Biol Res, V27, P205
[7]  
Arruzazabala M. L., 1991, REV CENIC CIENC BIOL, V22, P60
[8]   EFFECTS OF POLICOSANOL ON PLATELET-AGGREGATION IN RATS [J].
ARRUZAZABALA, ML ;
CARBAJAL, D ;
MAS, R ;
GARCIA, M ;
FRAGA, V .
THROMBOSIS RESEARCH, 1993, 69 (03) :321-327
[9]  
ATKINSON D, 1989, ATHEROSCLEROSIS, V79, P123
[10]   ANTIATHEROSCLEROTIC ACTIVITY OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME-A REDUCTASE IN CHOLESTEROL-FED RABBITS - A BIOCHEMICAL AND MORPHOLOGICAL EVALUATION [J].
BOCAN, TMA ;
MAZUR, MJ ;
MUELLER, SB ;
BROWN, EQ ;
SLISKOVIC, DR ;
OBRIEN, PM ;
CRESWELL, MW ;
LEE, H ;
UHLENDORF, PD ;
ROTH, BD ;
NEWTON, RS .
ATHEROSCLEROSIS, 1994, 111 (01) :127-142